<?xml version="1.0" encoding="UTF-8"?>
<p id="par0055">The leading cause for mortality of patients with COVID-19 is respiratory failure from acute respiratory distress syndrome [
 <xref rid="bib0175" ref-type="bibr">35</xref>]. Secondary hemophagocytic lymphohistiocytosis (sHLH) is characterized by fulminant and fatal hypercytokinemia with multiorgan failure, and it is underrecognized. Viral infection triggers sHLH and occurs in 3.7%–4.3% of sepsis cases in adults [
 <xref rid="bib0180" ref-type="bibr">36</xref>,
 <xref rid="bib0185" ref-type="bibr">37</xref>]. sHLH, resembled by a cytokine profile, is associated with COVID-19 disease severity, characterized by increased interleukin (IL)-2, IL-7, interferon-inducible protein 10, granulocyte-colony stimulating factor, macrophage inflammatory protein 1-, monocyte chemoattractant protein 1, and tumor necrosis factor- (TNF-) [
 <xref rid="bib0190" ref-type="bibr">38</xref>]. A recent retrospective fatality predictor’s multicenter study of 150 confirmed COVID-19 cases in Wuhan, China, included elevated ferritin and IL-6, suggesting that mortality might due to virally driven hyperinflammation [
 <xref rid="bib0195" ref-type="bibr">39</xref>].
</p>
